...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior.
【24h】

Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior.

机译:小肝细胞癌的病理生物学特征:肿瘤大小与生物学行为之间的相关性。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: Increasing evidence has suggested that tumor size is one of the independent prognostic factors of patients with hepatocellular carcinoma (HCC). However, the criteria used to determine when HCC should be classified as small remain controversial. Our objective was to evaluate the relationship between the size of HCC and its clinicopathological features. METHODS: A retrospective study on 618 patients who underwent partial hepatectomy for solitary HCC was performed. These patients were divided into Groups 1-5 according to the tumor diameter: 5 cm, respectively. The clinicopathological variables of the patients in each group were compared statistically. RESULTS: Except for the microHCC ( 3 cm. If 3 cm for large HCC (LHCC), significant differences (P < 0.05-0.01) were observed between SHCC and LHCC in: histological grades I-II (48.0 vs. 19.4 %), capsular invasion (15.4 vs. 36.3%), tumor thrombi (6.9 vs. 23.5%), satellite nodules (12.3 vs. 35.5%), noninvasive growth patterns (69.6 vs. 25.4%), the overall survival (OS, 119.6 +/- 34.7 vs. 68.5 +/- 6.6 months), and the recurrence-free survival (RFS, 67.0 +/- 16.7 vs. 29.5 +/- 3.2 months). Multivariate Cox regression analyses show that tumor size >3 cm was one of the independent prognostic factors for both OS and RFS. CONCLUSIONS: The 3 cm cutoff seems to best determine the biological behavior and clinical prognosis of patients undergoing partial hepatectomy for early stage HCC. Overall, HCC smaller than 3 cm in diameter was closely related with a better prognosis which reflected the relatively benign pathobiological features at an early developmental stage. As HCC > 3 cm exhibited a tendency towards more aggressive behavior, we suggest that HCC
机译:目的:越来越多的证据表明,肿瘤大小是肝细胞癌(HCC)患者的独立预后因素之一。但是,用于确定何时将HCC归类为“小”的标准仍然存在争议。我们的目的是评估肝癌的大小与其临床病理特征之间的关系。方法:回顾性分析了618例行部分肝切除术治疗孤立性HCC的患者。根据肿瘤直径将这些患者分为1-5组:分别为 5 cm。对每组患者的临床病理变量进行统计学比较。结果:除了microHCC( 3 cm的HCC之间几乎没有差异。如果将 3 cm作为大肝癌(LHCC)的分界点,则在以下方面观察到SHCC和LHCC之间存在显着差异(P <0.05-0.01): I-II级(48.0 vs. 19.4%),荚膜浸润(15.4 vs.36.3%),肿瘤血栓(6.9 vs. 23.5%),卫星结节(12.3 vs.35.5%),无创生长模式(69.6 vs. 25.4) %),总生存期(OS,119.6 +/- 34.7与68.5 +/- 6.6个月)和无复发生存期(RFS,67.0 +/- 16.7与29.5 +/- 3.2个月)。多变量Cox回归分析显示,肿瘤大小> 3 cm是OS和RFS的独立预后因素之一。结论:3 cm的临界值似乎最能确定早期肝癌患者接受部分肝切除术的生物学行为和临床预后。总体而言,直径小于3 cm的HCC与预后较好密切相关,这反映了在早期发育阶段相对良性的病理生物学特征。由于HCC> 3 cm表现出趋于更具侵略性的趋势,因此我们建议,应将直径HCC≤3 cm用作SHCC的临界尺寸,在该尺寸下,治愈性治疗可达到更好的长期生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号